Agency Information Collection Activities: Submission for OMB Review; Comment Request, 16516-16518 [2013-06029]
Download as PDF
<![CDATA[
16516
Federal Register / Vol. 78, No. 51 / Friday, March 15, 2013 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Clinical Trial
Implementation.
Date: April 8, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Gregory P. Jarosik, Ph.D.,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, 301–496–0695,
gjarosik@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 11, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Multidisciplinary
K12 Urological Research Career Development
Program.
Date: April 4, 2013.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7791,
goterrobinsonc@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 11, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–05969 Filed 3–14–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
Substance Abuse and Mental Health
Services Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
[FR Doc. 2013–05968 Filed 3–14–13; 8:45 am]
srobinson on DSK4SPTVN1PROD with NOTICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
VerDate Mar<14>2013
17:37 Mar 14, 2013
Jkt 229001
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Project: Opioid Drugs in Maintenance
and Detoxification Treatment of Opioid
Dependence—42 CFR Part 8 and Opioid
Treatment Programs (OTPs) (OMB No.
0930–0206)—Revision
42 CFR part 8 establishes a
certification program managed by
SAMHSA’s Center for Substance Abuse
Treatment (CSAT). The regulation
requires that Opioid Treatment
Programs (OTPs) be certified.
‘‘Certification’’ is the process by which
SAMHSA determines that an OTP is
qualified to provide opioid treatment
under the Federal opioid treatment
standards established by the Secretary
of Health and Human Services. To
become certified, an OTP must be
accredited by a SAMHSA-approved
accreditation body. The regulation also
provides standards for such services as
individualized treatment planning,
increased medical supervision, and
assessment of patient outcomes. This
submission seeks continued approval of
the information collection requirements
in the regulation and of the forms used
in implementing the regulation.
SAMHSA currently has approval for
the Application for Certification to Use
Opioid Drugs in a Treatment Program
Under 42 CFR 8.11 (Form SMA–162);
the Application for Approval as
Accreditation Body Under 42 CFR 8.3(b)
(Form SMA–163); and the Exception
Request and Record of Justification
Under 42 CFR 8.12 (Form SMA–168),
which may be used on a voluntary basis
by physicians when there is a patient
care situation in which the physician
must make a treatment decision that
differs from the treatment regimen
required by the regulation. Form SMA–
168 is a simplified, standardized form to
facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the
recordkeeping requirements in the
regulation are customary and usual
practices within the medical and
rehabilitative communities and has not
calculated a response burden for them.
The recordkeeping requirements set
forth in 42 CFR 8.4, 8.11 and 8.12
include maintenance of the following: 5year retention by accreditation bodies of
certain records pertaining to
accreditation; documentation by an OTP
of the following: A patient’s medical
examination when admitted to
treatment, A patient’s history, a
treatment plan, any prenatal support
provided the patient, justification of
unusually large initial doses, changes in
a patient’s dosage schedule, justification
of unusually large daily doses, the
rationale for decreasing a patient’s clinic
E:\FR\FM\15MRN1.SGM
15MRN1
16517
Federal Register / Vol. 78, No. 51 / Friday, March 15, 2013 / Notices
attendance, and documentation of
physiologic dependence.
The rule also includes requirements
that OTPs and accreditation
organizations disclose information. For
example, 42 CFR 8.12(e)(1) requires that
a physician explain the facts concerning
the use of opioid drug treatment to each
patient. This type of disclosure is
considered to be consistent with the
common medical practice and is not
considered an additional burden.
Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations
shall make public their fee structure;
this type of disclosure is standard
business practice and is not considered
a burden.
There are no changes being made to
the forms. The reason for the reduction
in burden hours is due to more
respondents submitting information
through an online function. The forms
are available online with a unique
feature for both the SMA–162 and
SMA–168 that pre-populates certain
information within the form. This in
turn reduces the program’s time spent
filling out the forms as well as the staff
time spent on processing it. Also, a final
rule effective January 7, 2013, (77 FR
72752, Federal Register December 6,
2012) eliminated dispensing restrictions
for buprenorphine products used in
OTPs. As a result there OTPs will
complete and submit fewer SMA–168
forms, therefore reducing burden hours.
The tables that follow summarize the
annual reporting burden associated with
the regulation, including burden
associated with the forms.
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR ACCREDITATION BODIES
Number of
respondents
Responses/
respondent
Total
responses
Hours/
response
Total
hours
42 CFR citation
Purpose
8.3(b)(1–11) .......................
8.3(c) .................................
8.3(e) .................................
8.3(f)(2) ..............................
8.4(b)(1)(ii) .........................
8.4(b)(1)(iii) ........................
8.4(d)(1) .............................
1
2
1
1
2
2
6
1
1
1
90
2
10
5
1
2
1
90
4
20
30
6.0
1.0
0.5
0.1
1.0
1.0
0.5
6
2
0.5
9
4
20
15
8.4(d)(2) .............................
8.4(d)(3) .............................
8.4(d)(4) .............................
8.4(d)(5) .............................
8.4(e) .................................
8.6(a)(2) and (b)(3) ...........
8.6(b) .................................
8.6(b)(1) .............................
Initial approval (SMA–163) ................................................
Renewal of approval (SMA–163) ......................................
Relinquishment notification ...............................................
Non-renewal notification to accredited OTPs ...................
Notification to SAMHSA for seriously noncompliant OTPs
Notification to OTP for serious noncompliance ................
General documents and information to SAMHSA upon
request.
Accreditation survey to SAMHSA upon request ...............
List of surveys, surveyors to SAMHSA upon request ......
Report of less than full accreditation to SAMHSA ............
Summaries of Inspections .................................................
Notifications of Complaints ................................................
Revocation notification to Accredited OTPs .....................
Submission of 90-day corrective plan to SAMHSA ..........
Notification to accredited OTPs of Probationary Status ...
6
6
6
6
12
1
1
1
75
6
5
50
6
185
1
185
450
36
30
300
72
185
1
185
0.02
0.2
0.5
0.5
0.5
0.3
10
0.3
9
7.2
15
150
36
55.5
10.0
55.0
Sub Total ....................
............................................................................................
54
........................
1,407
....................
394.20
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR OPIOID TREATMENT PROGRAMS
Number of
respondents
42 CFR citation
Purpose
8.11(b) .........................
8.11(b) .........................
8.11(e)(1) .....................
8.11(e)(2) .....................
Renewal of approval (SMA–162) ..........
Relocation of Program (SMA–162) .......
Application for provisional certification ..
Application for extension of provisional
certification.
Notification of sponsor or medical director change (SMA–162).
Documentation to SAMHSA for interim
maintenance.
Request to SAMHSA for Exemption
from 8.11 and 8.12 (including SMA–
168).
Notification to SAMHSA Before Establishing Medication Units (SMA–162).
Notification to State Health Officer
When Patient Begins Interim Maintenance.
Contents of Appellant Request for Review of Suspension.
Informal Review Request ......................
Appellant’s Review File and Written
Statement.
Appellant’s Request for Expedited Review.
Appellant Review File and Written
Statement.
8.11(f)(5) ......................
8.11(g)(2) .....................
8.11(h) .........................
8.11(i)(1) ......................
8.12(j)(2) ......................
8.24 ..............................
srobinson on DSK4SPTVN1PROD with NOTICES
8.25(a) .........................
8.26(a) .........................
8.28(a) .........................
8.28(c) ..........................
Responses/
respondent
Total
responses
Hours/
response
Total hours
386
35
42
30
1
1
1
1
386
35
42
30
0.15
1.17
1
0.25
57.9
40.95
42.00
7.50
60
1
60
0.1
6.00
1
1
1
1
1.00
1,200
20
24,000
0.07
1680
10
1
10
0.25
2.5
1
20
20
0.33
6.6
2
1
2
0.25
.50
2
2
1
1
2
2
1.00
5.00
2.00
10.00
2
1
2
1.00
2.00
2
1
2
5.00
10.00
Sub Total ..............
................................................................
1,775
........................
24,594
....................
1868.95
Total ..............
................................................................
1,829
........................
26,001
....................
2,263.15
VerDate Mar<14>2013
17:37 Mar 14, 2013
Jkt 229001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\15MRN1.SGM
15MRN1
16518
Federal Register / Vol. 78, No. 51 / Friday, March 15, 2013 / Notices
Written comments and
recommendations concerning the
proposed information collection should
be sent by April 15, 2013 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2013–06029 Filed 3–14–13; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
the emergency department following a
suicide attempt. Patient data will be
collected for patients admitted for a
suicide attempt in the two years prior to
collaboration between the emergency
department and crisis center and for
patients admitted for a suicide attempt
for the 2-year period after collaboration.
(1) The Hospital Data Abstraction
Form will be utilized to collect
systematic patient data for patients seen
in one of the two participating hospital
emergency departments. Information to
be abstracted from patient data include:
Demographic data, historical data, and
subsequent suicidal behavioral and
admission data. Data will be deidentified. Hospital staff will review
patient data for qualifying (i.e.,
admission to the emergency department
for suicide attempt) records. Records to
be reviewed will include emergency
department admissions for the two years
prior to crisis center and hospital
emergency department collaboration
and for two years following
collaboration. It is expected that a total
of 2,000 records will be abstracted by
hospital staff and provided to the
evaluation team.
(2) The Crisis Center Data Abstraction
Form will be utilized to collect
systematic crisis center data for patient
records for whom hospital data were
collected. Data will be de-identified and
will only contain a patient identification
number to match to the patient ID
provided through hospital records.
The estimated response burden to
collect this information is as follows
annualized over the requested 3-year
clearance period is presented below:
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Evaluation of Emergency
Department Crisis Center Follow-Up—
New
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Mental Health
Services (CMHS) will conduct an
evaluation to assess the impact of crisis
center follow-up with patients admitted
to emergency departments following a
suicide attempt.
The overarching purpose of the
proposed Evaluation of Emergency
Department Crisis Center Follow-up—
New is to examine the impact of crisis
center follow-up with patients admitted
to emergency departments following a
suicide attempt on subsequent
emergency department readmissions. In
total this evaluation effort includes two
data collection activities.
Clearance is being requested to
abstract patient hospital data and
companion crisis center data to examine
the impact of crisis center follow-up on
readmissions to the emergency
department for suicidal behavior. The
data collected through this project will
ultimately help SAMHSA to understand
and direct crisis center follow-up
lifesaving initiatives. The data
collection activities are described
below.
Two funded crisis centers, working in
collaboration with two hospital
emergency departments, will provide
follow-up services to patients seen in
TOTAL AND ANNUALIZED AVERAGES: RESPONDENTS, RESPONSES AND HOURS
Responses
per
respondent *
Number of
respondents
Instrument
Total number
of responses
Burden per
response
Annual
burden *
Hospital Data Abstraction Form ...........................................
Crisis Center Data Abstraction Form ...................................
2
2
334
167
667
333
.04
.04
27
13
Total ..............................................................................
4
........................
........................
........................
40
srobinson on DSK4SPTVN1PROD with NOTICES
* Rounded to the nearest whole number.
Written comments and
recommendations concerning the
proposed information collection should
be sent by April 15, 2013 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
VerDate Mar<14>2013
20:25 Mar 14, 2013
Jkt 229001
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2013–06004 Filed 3–14–13; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 78, Number 51 (Friday, March 15, 2013)]
[Notices]
[Pages 16516-16518]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06029]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.
Project: Opioid Drugs in Maintenance and Detoxification Treatment of
Opioid Dependence--42 CFR Part 8 and Opioid Treatment Programs (OTPs)
(OMB No. 0930-0206)--Revision
42 CFR part 8 establishes a certification program managed by
SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation
requires that Opioid Treatment Programs (OTPs) be certified.
``Certification'' is the process by which SAMHSA determines that an OTP
is qualified to provide opioid treatment under the Federal opioid
treatment standards established by the Secretary of Health and Human
Services. To become certified, an OTP must be accredited by a SAMHSA-
approved accreditation body. The regulation also provides standards for
such services as individualized treatment planning, increased medical
supervision, and assessment of patient outcomes. This submission seeks
continued approval of the information collection requirements in the
regulation and of the forms used in implementing the regulation.
SAMHSA currently has approval for the Application for Certification
to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 (Form SMA-
162); the Application for Approval as Accreditation Body Under 42 CFR
8.3(b) (Form SMA-163); and the Exception Request and Record of
Justification Under 42 CFR 8.12 (Form SMA-168), which may be used on a
voluntary basis by physicians when there is a patient care situation in
which the physician must make a treatment decision that differs from
the treatment regimen required by the regulation. Form SMA-168 is a
simplified, standardized form to facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the recordkeeping requirements in the
regulation are customary and usual practices within the medical and
rehabilitative communities and has not calculated a response burden for
them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and
8.12 include maintenance of the following: 5-year retention by
accreditation bodies of certain records pertaining to accreditation;
documentation by an OTP of the following: A patient's medical
examination when admitted to treatment, A patient's history, a
treatment plan, any prenatal support provided the patient,
justification of unusually large initial doses, changes in a patient's
dosage schedule, justification of unusually large daily doses, the
rationale for decreasing a patient's clinic
[[Page 16517]]
attendance, and documentation of physiologic dependence.
The rule also includes requirements that OTPs and accreditation
organizations disclose information. For example, 42 CFR 8.12(e)(1)
requires that a physician explain the facts concerning the use of
opioid drug treatment to each patient. This type of disclosure is
considered to be consistent with the common medical practice and is not
considered an additional burden. Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations shall make public their fee
structure; this type of disclosure is standard business practice and is
not considered a burden.
There are no changes being made to the forms. The reason for the
reduction in burden hours is due to more respondents submitting
information through an online function. The forms are available online
with a unique feature for both the SMA-162 and SMA-168 that pre-
populates certain information within the form. This in turn reduces the
program's time spent filling out the forms as well as the staff time
spent on processing it. Also, a final rule effective January 7, 2013,
(77 FR 72752, Federal Register December 6, 2012) eliminated dispensing
restrictions for buprenorphine products used in OTPs. As a result there
OTPs will complete and submit fewer SMA-168 forms, therefore reducing
burden hours.
The tables that follow summarize the annual reporting burden
associated with the regulation, including burden associated with the
forms.
Estimated Annual Reporting Requirement Burden for Accreditation Bodies
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/ Total
42 CFR citation Purpose respondents respondent responses response hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
8.3(b)(1-11).................................. Initial approval (SMA-163)....... 1 1 1 6.0 6
8.3(c)........................................ Renewal of approval (SMA-163).... 2 1 2 1.0 2
8.3(e)........................................ Relinquishment notification...... 1 1 1 0.5 0.5
8.3(f)(2)..................................... Non-renewal notification to 1 90 90 0.1 9
accredited OTPs.
8.4(b)(1)(ii)................................. Notification to SAMHSA for 2 2 4 1.0 4
seriously noncompliant OTPs.
8.4(b)(1)(iii)................................ Notification to OTP for serious 2 10 20 1.0 20
noncompliance.
8.4(d)(1)..................................... General documents and information 6 5 30 0.5 15
to SAMHSA upon request.
8.4(d)(2)..................................... Accreditation survey to SAMHSA 6 75 450 0.02 9
upon request.
8.4(d)(3)..................................... List of surveys, surveyors to 6 6 36 0.2 7.2
SAMHSA upon request.
8.4(d)(4)..................................... Report of less than full 6 5 30 0.5 15
accreditation to SAMHSA.
8.4(d)(5)..................................... Summaries of Inspections......... 6 50 300 0.5 150
8.4(e)........................................ Notifications of Complaints...... 12 6 72 0.5 36
8.6(a)(2) and (b)(3).......................... Revocation notification to 1 185 185 0.3 55.5
Accredited OTPs.
8.6(b)........................................ Submission of 90-day corrective 1 1 1 10 10.0
plan to SAMHSA.
8.6(b)(1)..................................... Notification to accredited OTPs 1 185 185 0.3 55.0
of Probationary Status.
----------------------------------------------------------------------
Sub Total................................. ................................. 54 .............. 1,407 ........... 394.20
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/
42 CFR citation Purpose respondents respondent responses response Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
8.11(b)....................................... Renewal of approval (SMA-162).... 386 1 386 0.15 57.9
8.11(b)....................................... Relocation of Program (SMA-162).. 35 1 35 1.17 40.95
8.11(e)(1).................................... Application for provisional 42 1 42 1 42.00
certification.
8.11(e)(2).................................... Application for extension of 30 1 30 0.25 7.50
provisional certification.
8.11(f)(5).................................... Notification of sponsor or 60 1 60 0.1 6.00
medical director change (SMA-
162).
8.11(g)(2).................................... Documentation to SAMHSA for 1 1 1 1 1.00
interim maintenance.
8.11(h)....................................... Request to SAMHSA for Exemption 1,200 20 24,000 0.07 1680
from 8.11 and 8.12 (including
SMA-168).
8.11(i)(1).................................... Notification to SAMHSA Before 10 1 10 0.25 2.5
Establishing Medication Units
(SMA-162).
8.12(j)(2).................................... Notification to State Health 1 20 20 0.33 6.6
Officer When Patient Begins
Interim Maintenance.
8.24.......................................... Contents of Appellant Request for 2 1 2 0.25 .50
Review of Suspension.
8.25(a)....................................... Informal Review Request.......... 2 1 2 1.00 2.00
8.26(a)....................................... Appellant's Review File and 2 1 2 5.00 10.00
Written Statement.
8.28(a)....................................... Appellant's Request for Expedited 2 1 2 1.00 2.00
Review.
8.28(c)....................................... Appellant Review File and Written 2 1 2 5.00 10.00
Statement.
----------------------------------------------------------------------
Sub Total................................. ................................. 1,775 .............. 24,594 ........... 1868.95
======================================================================
Total................................. ................................. 1,829 .............. 26,001 ........... 2,263.15
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 16518]]
Written comments and recommendations concerning the proposed
information collection should be sent by April 15, 2013 to the SAMHSA
Desk Officer at the Office of Information and Regulatory Affairs,
Office of Management and Budget (OMB). To ensure timely receipt of
comments, and to avoid potential delays in OMB's receipt and processing
of mail sent through the U.S. Postal Service, commenters are encouraged
to submit their comments to OMB via email to: OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send
their comments via email, commenters may also fax their comments to:
202-395-7285. Commenters may also mail them to: Office of Management
and Budget, Office of Information and Regulatory Affairs, New Executive
Office Building, Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2013-06029 Filed 3-14-13; 8:45 am]
BILLING CODE 4162-20-P
